Lenalidomide
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Application of PD-1 Inhibitors, Tenofovir, Chidamide, and Lenalidomide in Relapsed/Refractory EBV-associated Lymphoproliferative Disorders. (NCT07133763) | The Affiliated Hospital of Xuzhou Medical University | 2025-09-01 |
| Application of PD-1 Inhibitors Combined With Tenofovir, Chidamide and Lenalidomide in the Treatment of EBV-associated Diseases. (NCT07133776) | The Affiliated Hospital of Xuzhou Medical University | 2025-09-01 |
| Efficacy and Safety of Lenalidomide Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma (NCT04922567) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2021-04-01 |
Track Lenalidomide automatically
Every clearance here is in the API, with alerts when new ones post.